Navigation Links
Clinical Site Services, Industry Leader in Patient Enrollment Solutions, Announces New Website
Date:8/28/2012

GLEN BURNIE, Md., Aug. 28, 2012 /PRNewswire/ -- Clinical Site Services (CSS), a leader in patient enrollment solutions for the clinical research industry, is proud to announce the launch of its redesigned website, www.ClinicalSiteServices.com.

"The first thing that visitors will notice is our individuality," shared CSS President Chris Trizna. "Yes, we are part of the patient recruitment industry, but where we differ is our focus:  our unique ability to make an impact on enrollment at each site."

This new website will provide enhanced details for sponsor companies, CROs and investigative sites who are seeking targeted data on CSS's offerings and experience, including case studies, a creative portfolio and a summary of services. Clients will be able to view real-time Facebook, Twitter, LinkedIn and YouTube feeds on the home page.

"Take a look at the case studies," added Trizna. "Clients can see where CSS's involvement positively impacts enrollment, not just responses, referrals or recruitment."

Future online offerings will include a blog centered around current patient recruitment trends and difficulties. CSS will also feature "Town Hall" style opportunities for discussion and review of specific patient recruitment challenges.

About Clinical Site Services

Clinical Site Services (CSS) is a site performance company that provides solutions to increase the enrollment potential for investigative sites. Through a proprietary, integrated process, CSS strives to reduce the costs and timeliness associated with recruitment subjects for clinical studies.

For More Information

Visit www.ClinicalSiteServices.com, or contact Jennifer Whitlock, Vice President, at jwhitlock@clinicalsiteservices.com or 443-308-5803.

This press release was issued through eRel
'/>"/>

SOURCE Clinical Site Services
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Elsevier / Gold Standard Announces New Drug Class Overviews for Clinical Pharmacology
2. Clinical Phase Ia Trial on MIV-711 Complete and Phase Ib Trial Commences
3. Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder Treatment
4. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
5. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
6. Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
7. Infectious Disease Prevalence and New Strains Appearing Each Year Makes a Watertight Case for Clinical Laboratory Testing, Finds Frost & Sullivan
8. Clinical Site Services Chris Trizna Contributing Author in Diana Anderson-Fosters Newest Release Global Issues in Patient Recruitment and Retention
9. ERT Granted Patents on Clinical Trial Participant Compliance
10. Life Technologies to Accelerate Development of Ion Torrent Semiconductor Technology for Proteomic Applications in Research, Applied and Clinical Markets
11. Healthcare Cloud Computing (Clinical, EMR, SaaS, Private, Public, Hybrid) Market - Global Trends, Challenges, Opportunities & Forecasts (2012 - 2017)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... (PRWEB) September 30, 2014 ... solutions for drug discovery and related life ... consortium has chosen Genedata Selector as its ... (NGS) data. FUNGITECT is a European consortium ... fungal diseases via individualized anti-fungal drug therapies. ...
(Date:9/30/2014)... CORALVILLE, Iowa , Sept. 30, 2014 /PRNewswire/ ... in the discovery and development of proprietary new ... United States Patent and Trademark Office (USPTO) issued ... patent application entitled, "Benzoic Acid, Benzoic Acid Derivatives ... Methods of Making and Use Thereof." ...
(Date:9/30/2014)... MAR, Calif. , Sept. 30, 2014 ... for women,s health announces its receipt of a patent ... FemmyCycle menstrual cup has also received FDA clearance in ... Canada, and the CE in Europe. This patent is related ... conjunction with this issuance, the company is releasing FemmyCycle ...
(Date:9/30/2014)... LONDON , Sept. 30, 2014 ... analyze global next-generation (NGS) sequencing trends and use. ... technology use is expected to increase within the ... are the top criteria for purchasing sequencing instruments. ... technologies. The popularity of RNA-Seq continues to surge, ...
Breaking Biology Technology:FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2The FemmyCycle 2Global Next-generation Sequencing Trends 2
... ATLANTA, Nov. 6, 2010 Alder Biopharmaceuticals Inc. today announced ... antibody therapeutic will be presented at the Annual Meeting of ... continue to be encouraged about the clinical data from the ... for the first time, from our Phase 1 study of ...
... Inc. (Nasdaq: CLRT ) announced today that its ... stockholders tender their shares to General Electric Company (NYSE: ... per share of Clarient,s common stock and $20.00 per share ... transaction is expected to close during the fourth quarter of ...
... CAMBRIDGE, Mass., Nov. 5, 2010 Metamark Genetics, Inc., ... the appointment of Mark R. Straley as the company,s ... Board of Directors. Kenneth E. Weg, a Metamark co-founder ... serve as Chairman of the Board of Directors. ...
Cached Biology Technology:Alder Biopharmaceuticals Announces That Data From Multiple Studies of ALD518 (BMS945429), an Investigational Antibody Therapeutic in Rheumatoid Arthritis Patients, to be Presented at Annual Meeting of the American College of Rheumatology 2Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer 2Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer 3Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer 4Metamark Genetics, Inc. Announces New Chief Executive Officer 2
(Date:9/29/2014)... culture, mathematics is often deemed inaccessible or esoteric. Yet ... important role in our daily lives and a decisive ... often behind the scenes. , UC Santa Barbara,s ... and an assistant professor of mechanical engineering, often works ... his recent research published in the Proceedings of ...
(Date:9/29/2014)... of dinosaurs, gigantic reptilesdistant relatives of modern crocodilesruled the ... and it was thought they didn,t much interact. But ... researcher in the thigh of one of these ancient ... an earth and planetary sciences lecturer, and her Virginia ... bite marks in the thigh bones of an old ...
(Date:9/29/2014)... , Canda, September 29, 2014 ... as UID Coupled with Increasing Security Concerns Continue ... India is one of ... increasing adoption of biometrics systems, majorly in various ... NREGA, etc. Fingerprint modality based biometrics dominates the ...
Breaking Biology News(10 mins):At the interface of math and science 2At the interface of math and science 3At the interface of math and science 4Tooth serves as evidence of 220 million-year-old attack 2India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 2India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 3
... Through a collaborative genome-wide study on individuals, researchers ... with heart rate. Since heart rate is a ... better understanding of genetic regulation of heart beat and ... drugs to treat cardiovascular disease. The study, titled, ...
... can keep clogged leg arteries open, preventing amputation ... the Society of Interventional Radiology,s 38th Annual Scientific ... (or PAD) is becoming increasingly prevalent due to ... epidemics," said Robert A. Lookstein, M.D., FSIR, lead ...
... WEST ORANGE, N.J.The State of Spinal Cord Injury: Latest ... Recovery will be held on Wednesday, April 17, 2013, ... Pleasant Valley Way, West Orange, N.J. This special Grand ... Cord Injury System (NNJSCIS) and the Spinal Cord Injury ...
Cached Biology News:Mount Sinai study identifies new gene variations associated with heart rate 2Drug-coated stents prevent leg amputation 2The State of Spinal Cord Injury Grand Rounds 2
Prepared from plasminogen by activation with immobilized human uPA...
(3-[125I]iodotyrosyl26)Galanin (porcine), 925 kBq, 25 uCi. Category: IODINE LIGANDS....
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse Endoglin/CD105 Fluorescein MAb (Clone 209701)...
Biology Products: